IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11969471 B1

PDFFull Text
Date of Patent:
Apr. 30, 2024

Filed:

Aug. 02, 2022

Pharmaceutical compositions and related methods of delivery

Applicant:

Amryt Endo, Inc., Needham, MA (US);

Inventors:

Roni Mamluk, Mazkeret Batya, IL;

Moshe Tzabari, Jerusalem, IL;

Karen Marom, Mevaseret Zion, IL;

Paul Salama, Ashdod, IL;

Irina Weinstein, Maale Adummim, IL;

Assignee:

Amryt Endo, Inc., Boston, MA (US);

Attorney:

COOLEY LLP

Primary Examiner:

James W Rogers

Int. Cl.
CPC ...
A61K 47/44 (2017.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/48 (2006.01); A61K 31/70 (2006.01); A61K 31/7036 (2006.01); A61K 31/713 (2006.01); A61K 31/721 (2006.01); A61K 38/08 (2019.01); A61K 38/09 (2006.01); A61K 38/095 (2019.01); A61K 38/12 (2006.01); A61K 38/14 (2006.01); A61K 38/21 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 38/29 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 9/16 (2006.01); A61K 51/08 (2006.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
A61K 47/44 (2013.01); A61K 9/0031 (2013.01); A61K 9/0053 (2013.01); A61K 9/10 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/4891 (2013.01); A61K 31/70 (2013.01); A61K 31/7036 (2013.01); A61K 31/713 (2013.01); A61K 31/721 (2013.01); A61K 38/08 (2013.01); A61K 38/09 (2013.01); A61K 38/095 (2019.01); A61K 38/12 (2013.01); A61K 38/14 (2013.01); A61K 38/212 (2013.01); A61K 38/22 (2013.01); A61K 38/26 (2013.01); A61K 38/27 (2013.01); A61K 38/28 (2013.01); A61K 38/29 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 9/1623 (2013.01); A61K 51/083 (2013.01); A61K 51/1021 (2013.01); A61K 51/1024 (2013.01); A61K 51/1045 (2013.01);
Abstract

The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.

Find Patent Forward Citations

Loading…